Onconetix, Inc. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Onconetix, Inc. (ONCO) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 70.85 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2023-11-17
- Onconetix, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-09-30 was 0.00 shares.
- Onconetix, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-06-30 was 0.00 shares.
- Onconetix, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-03-31 was 70.85K shares.
- Onconetix, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2022-12-31 was 0.00 shares.
- Onconetix, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2022 was 70.85K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-17 | 70.85K shares 10-Q · filed 2023-11-17 | 70.85K shares derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | 70.85K shares 10-Q · filed 2023-10-20 | 70.85K shares derived: sum of 3 quarters · filed 2023-10-20 | |
| 2023-03-31 | 70.85K shares 10-Q · filed 2023-05-12 | 70.85K shares derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 70.85K shares 10-K · filed 2023-03-09 | ||
| 2022-09-30 | 70.85K shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |